.Attributes Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view requires introduction of individuals with MASLD and size of liver end results in cardio-- kidney-- metabolic trials, when information advise mechanistically conceivable benefits and also professional safety-- and also details factors for trial concept and also regulative approval.